Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3100
-0.0060 (-1.90%)
Sep 23, 2026, 9:01 AM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 92.24 million as of September 22, 2026. Its market cap has decreased by -45.07% in one year.
Market Cap
92.24M
Enterprise Value
46.68M
Revenue
14.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.31
ChartMarket Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 92.24M, a decrease of -56.07%. That is a compound annual growth rate of -8.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 92.24M | -14.59% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xintela AB | 143.83M |
| Simris Group AB (PUBL) | 139.70M |
| NextCell Pharma AB | 136.25M |
| Active Biotech AB | 107.95M |
| Nanologica AB | 101.92M |
| Alzinova AB | 87.14M |
| Pila Pharma AB | 85.43M |
| Ascelia Pharma AB | 81.19M |